Pediatrik Nöroloji Pratiğinde Genetik Testlerin Kullanımı
Özet
Genetik testler, kromozom, DNA ve protein düzeyindeki değişimleri analiz ederek hastalıkların tanı sürecinde doğruluk, maliyet etkinliği ve hız sağlayan kritik araçlardır. Bu testler, doğru klinik danışmanlık ve hekim-laboratuvar iş birliği ile kullanıldığında hastalıkların erken teşhisine, prognozun belirlenmesine ve ailevi risklerin yönetilmesine yardımcı olur. Ancak, sonuçların karmaşıklığı ve psikososyal etkileri göz önüne alınarak, test öncesi ve sonrası ailelere detaylı bilgilendirme yapılması zorunludur. Doğru tanı, en güncel yöntemden ziyade hastanın klinik öyküsüne ve semptomlarına uygun testin seçilmesine bağlıdır.
Genetic tests are critical tools that enhance the accuracy, cost-effectiveness, and speed of the diagnostic process by analyzing changes at the chromosome, DNA, and protein levels. When utilized with proper clinical counseling and physician-laboratory collaboration, these tests assist in early disease diagnosis, prognosis determination, and the management of familial risks. However, given the complexity of results and their psychosocial impact, it is essential to provide detailed information to families both before and after testing. An accurate diagnosis depends not on the latest method, but on selecting the appropriate test based on the patient's clinical history and symptoms.
Referanslar
McPerson E. Genetic Diagnosis and Testing in Clinical Practice. Clin Med Res. 2006;4(2):123-129.
Valente EM, Ferraris A., Dallapiccola B. Genetic testing for paediatric neurological disorders. Lancet Neurol. 2008;7(12):1113-26.
Katsanis SH, Katsanis N. Molecular genetic testing and the future of clinical genomics. Nat Rev Genet. 2013;14:415–426.
Horton RH, Anneke M. Lucassen Recent developments in genetic/genomic medicine. Clinical Science. 2019;133:697–708.
Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve. 2005Jul;32(1):1-18.
Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat. Rev. Genet. 2018;19,253–268.
Van Nimwegen VLE, Lisenka ELM, Vissers LEL, Schieving JH, et al. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet Med. 2017;19:1055–1063.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17,405–424.
Wright, CF, Fitzgerald, TW, Jones, WD, et al. (2015) Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 2015;385:1305–1314.
Raby BA, Kohlmann W, Slavotinec D. Genetic Testing. Uptodate. 2021.
Clayton EW. Ethical, legal, and social implications of genomic medicine. N Engl J Med 2003; 349:562.
Marteau TM, Croyle RT. The new genetics. Psychological responses to genetic testing. BMJ. 1998;316:693.
Hall JA, Gertz R, Amato J, Pagliari C. Transparency of genetic testing services for ‘health, wellness and lifestyle’: analysis of online prepurchase information for UK consumers. Eur J Hum Genet. 2017;25:908–917.
Amendola LM, Jarvik GP, Leo MC, et al. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet.2016;99:247.
Green, R.C., Berg, J.S., Grody, W.W. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–574.
Burke W. Genetic testing. N Engl J Med. 2002;347:1867–1875.
Khoury MJ. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med. 2003;5:261–268.
Mand C, Gillam L, Delatycki MB. and Duncan RE. Predictive genetic testing in minors for lateonset conditions: a chronological and analytical review of the ethical arguments. Journal of Medical Ethics. 2012;38:519-24.
Patch C, Anna Middleton A. Genetic counselling in the era of genomic medicine. Br Med Bull. 2018Jun;126(1): 27–36.
Middleton A, Marks P, Bruce A, et al. The role of genetic counsellors in genomic healthcare in the United Kingdom: a statement by the Association of Genetic Nurses and Counsellors. Eur J Hum Genet. 2017;25:659–61.
McAllister M, Moldovan R, Paneque M, et al. . The need to develop an evidence base for genetic counselling in Europe. Eur J Hum Genet 2016;24:504–5.
Lindstrand A, Eisfeldt J, Pettersson M. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability. Genome Med. 2019;11:68.
Bowling KM, Thompson ML, Amaral MD, et al. Genomic diagnosis for children with intellectual disability and/or developmental delay. Genome Med. 2017;9(1):43.
Boycott KM, Rath A, Chong JX, et al. International cooperation to enable the diagnosis of all rare genetic diseases. Am J Hum Genet. 2017;100(5):695–705.
Aref-Eshghi E, Rodenhiser DI, Schenkel LC, et al. Genomic DNA methylation signatures enable concurrent diagnosis and clinical genetic variant classification in neurodevelopmental syndromes. Am J Hum Genet. 2018;102:156–74.
Meienberg J, Bruggmann R, Oexle K, Matyas G. Clinical sequencing: is WGS the better WES? Hum Genet. 2016;135:359–62.
Bumgarner R. Overview of DNA microarrays: types, applications, and their future. Curr Protoc Mol Biol. 2013;101:22.
Lalonde E, Rentas S, Lin F, et al. Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution. Front Pediatr. 2020;8:373.
Tandy-Connor, S, Guiltinan, J, Krempely K, et al. False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care. Genet. Med. 2018;20:1515–1521,
Lee H, Deignan JL, Dorrani N, et al: Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312:1880–1887.
Yang Y, Muzny DM, Xia F, et al: Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312:1870–1879.
Kanzi AM, San JE, Chimukangara B. Next Generation Sequencing and Bioinformatics Analysis of Family Genetic Inheritance. Front Genet. 2020;11:544162.
Sawyer SL, Hartley T, Dyment DA, et al. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care. Clin Genet. 2016;89:275.
Tan TY, Dillon OJ, Stark Z, et al. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. JAMA Pediatr. 2017; 171:855.
Brenner's Encyclopedia of Genetics. 2nd ed. Maloy S, Hughes K (Eds). Elsevier. 2013.
Raby BA and Blank RD. Genetics: Glossary of terms. Uptodate. 2021.
